Hypoglycemic agent
Abstract
A zinc(II) complex which is lowly toxic, has high insulin-like activity, and is effectively usable as a hypoglycemic agent for the prevention or treatment of diabetes; a hypoglycemic agent containing the complex; a medicinal preparation which contains the complex and is useful as a preventive/remedy for diabetes; and a food containing the complex, such as a health food or supplementary health food. The hypoglycemic agent contains an organic zinc(II) complex having as a ligand a compound selected among aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, α- and β-hydroxycarboxylic acids, vitamins, glutamine derivatives, etc.
Claims
exact text as granted — not AI-modified1 - 26 . (canceled)
27 . Zinc(II) organic complexes having, as a ligand, a compound of a general formula (11):
(wherein X 0 − represents Cl − , Br or I − ).
28 - 30 . (canceled)Join the waitlist — get patent alerts
Track US2007155657A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.